Effect of health insurance type on health care utilization in patients with hypertension: a national health insurance database study in Korea by unknown
Suh et al. BMC Health Services Research 2014, 14:570
http://www.biomedcentral.com/1472-6963/14/570RESEARCH ARTICLE Open AccessEffect of health insurance type on health care
utilization in patients with hypertension: a
national health insurance database study in Korea
Hae Sun Suh1, Hye-Young Kang2*, Jinkyung Kim3 and Euichul Shin4Abstract
Background: Higher utilization of healthcare services has been observed among individuals who receive public aid
compared to individuals who do not receive public aid in many countries. However, no systematic investigations
have explored whether this pattern of higher utilization persists after correcting for a number of factors in Korea.
In this study, we sought to examine whether the type of health insurance, wage-based contributory insurance
(Health Insurance, HI) or government-subsidized public assistance (Medical Aid, MA), affects the utilization of
inpatient services after controlling for baseline patient and institutional characteristics among patients with
hypertension in Korea.
Methods: The Korean National Health Insurance claims database from 2006 and 2007 was used for analysis. To
avoid biased estimates, we determined the most appropriate type of multivariate model for each outcome variable:
a logistic regression model for the likelihood of hospitalization, a zero-inflated negative binomial model for the
length of stay (LOS), and a generalized linear model with a log-link function for hospitalization costs.
Results: Adjusted odds ratio (OR) and factor changes showed that MA patients (n = 21,539) had a significantly
higher likelihood of hospitalization (OR: 1.41-1.71), average LOS per patient (factor change: 1.31-1.42), and
hospitalization costs per patient (factor change: 1.10-1.41) compared to HI patients (n = 304,027).
Conclusions: The pattern of higher healthcare utilization among MA patients persists even after controlling for
baseline health conditions. This finding confirms that the type of health insurance affects the utilization of
healthcare resources, and suggests that effective strategies are necessary to prevent the potential overutilization of
inpatient care by MA patients with hypertension in Korea.
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One prominent adverse effect of providing health insur-
ance, especially under fee-for-service payment systems,
is the overutilization of care [1]. Beneficiaries of health
insurance without or with low co-payments are likely to
use more healthcare resources compared to those paying
higher co-payments [2,3]. This phenomenon has been
observed in Korea [4,5].
Korea has two tiers of the universal health insurance
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reproduction in any medium, provided the or(MA) program. The HI program is a wage-based, con-
tributory insurance program covering about 96% of
the population, and the MA program is a government-
subsidized public assistance program for poor and med-
ically indigent individuals [6]. Unlike many countries
such as the United States, the United Kingdom, Spain,
Italy, and Denmark, patients in Korea can consult spe-
cialists directly without seeing a gatekeeper [7]. With no
strict gate-keeping system, patients can easily access sec-
ondary care in tertiary hospitals, and there are no differ-
ences in the benefits provided to beneficiaries in the HI
and the MA programs [8].
According to the 2010 National Health Insurance sta-
tistics, the per-capita utilization and cost of insurance-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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those enrolled in the MA program compared to those in
the HI program. The average medical expenses per
beneficiary are three times higher and the average length
of stay is twice longer in the MA group than in the HI
group [4]. This raises a concern that individuals with
MA insurance might over-utilize healthcare and incur
unnecessary costs due to low co-payments or waivers of
co-payment. Conversely, some argue that those enrolled
in public assistance health insurance programs such as
the MA program use healthcare services more because
people with a low socioeconomic status tend to have
poorer health and are more susceptible to illness [9].
However, there have been no systematic investigations
as to whether the higher utilization by individuals with
MA insurance in Korea is due to poorer health or
greater use of healthcare resources.
Therefore, we compared the hospitalization rates re-
lated to hypertension between the HI and the MA
groups in Korea in an attempt to assess whether benefi-
ciaries of the MA program have higher utilization rates
of inpatient care than those in the HI program after con-
trolling for baseline health conditions. Hypertension is
one of the ‘ambulatory care sensitive conditions (ACSC)’,
which have been defined as health conditions for which
hospitalization can be avoided through timely and effect-
ive primary care in outpatient settings [10,11]. Per the
definition of ACSC, it is not common for patients with
hypertension to be hospitalized, as the blood pressure is
usually managed through medication therapy in an out-
patient setting. Thus, we selected hypertension in order
to study the possibility of unnecessary use of inpatient
services. Besides, hypertension was selected for this
comparison because it is a major risk factor for cardio-
vascular disease, which is the second highest cause of
mortality in Korea [12]. The disease burden of hyperten-
sion is expected to increase rapidly due to the aging of
the Korean population, and the amount of treatment
for hypertension ranks among the highest [4,5,13,14].
Therefore, a critical need exists to develop effective
treatment strategies to control hypertension and to effi-
ciently allocate healthcare resources. We hypothesized
that if higher admission rates by MA patients persisted
after adjustment for differences in baseline health condi-
tions and characteristics between the two groups, this
would indicate a potential overutilization of inpatient
care for hypertension among the MA group.
Methods
Data sources and study subjects
We have used the Korean National Health Insurance
(NHI) claims database obtained through a formal request
to the Health Insurance Review and Assessment Service
in Korea for research purpose because the database wasnot publicly available [15]. Records from the Korean NHI
claims database for two years, 2006 and 2007, were used
to identify HI and MA patients with hypertension and to
compare their healthcare utilization. We used all claims
records for enrollees of the HI and the MA programs who
were continuously enrolled between 2006 and 2007 and
were aged 19 or older at the index date. Patients were
identified as having hypertension if they had at least one
claim record (i.e., inpatient, outpatient, or emergency
department visit) with a primary, secondary, tertiary,
or quaternary diagnosis of hypertension (International
Classification of Diseases, Tenth Revision, Clinical Modifi-
cation (ICD-10-CM) billing codes of I10.x, I11.9, and
I13.9) during a six-month intake period from July 1 to De-
cember 31, 2006. Figure 1 depicts the three different ob-
servation periods employed in this study: baseline, intake,
and follow-up period. The date of the first claim of hyper-
tension during the intake period was defined as the index
date for each patient. For the efficiency of the data ana-
lysis, we randomly sampled 10% of the identified patients
in the HI and the MA group.
Figure 1 presents the sampling process used to identify
the target population. For each of the sampled patients,
baseline characteristics such as overall healthcare utili-
zation and comorbid conditions were observed for a
six-month baseline period before the index date to adjust
for baseline disease severity. In addition, hypertension-
related healthcare utilization, defined as any outpatient, in-
patient, or emergency department visit with a primary,
secondary, tertiary, or quaternary diagnosis of hyperten-
sion was tracked for each patient for a one-year follow-up
period after his or her index date. As a result, a total of
325,566 patients were included in the data analysis, com-
posed of patients enrolled in the HI program (n =304,027)
and in the MA program (n =21,539).
Study variables
Dependent variables
We defined three outcome measures as dependent vari-
ables to compare the likelihood and the extent of
utilization of inpatient services between HI and MA pa-
tients with hypertension: hospital admission, length of
stay (LOS), and hospitalization costs related to hyperten-
sion. The likelihood of being hospitalized with hyperten-
sion was operationalized as any occurrence of hospital
admission with a primary, secondary, tertiary, or quater-
nary diagnosis of hypertension during the one-year
follow-up period. The extent of inpatient services uti-
lized was measured as the total LOS and the total
insurance-covered medical costs of hospital admissions
for hypertension per patient during the one-year follow-
up period. For patients without any hospital admission
for hypertension, these two variables were given zero
values. The insurance-covered medical costs included
Figure 1 Study time period and identification of the target population.
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for the services listed on the NHI-covered services, and
captured all types of medical services as long as they
were covered by the NHI, such as charges for diagnostic
tests, medical procedures and pharmaceuticals, and
the accommodation costs for rooms and meals during
hospitalization.
Independent variables
The major independent variable in this study is the
health insurance type, HI or MA. The beneficiaries in
the MA group were further categorized into two sub-
groups: Class I with almost no co-payment (due to not
being able to work at all) and Class II with relativelyhigher co-payments than Class I (due to being able to
work). We did not categorized the beneficiaries in the
HI group as the MA group because the co-payment rate
in beneficiaries with Health Insurance varies by types of
services they used, types of institutions they visited, indi-
cations of services, etc.
We included selected baseline patients and institu-
tional characteristics observed during the six-month
baseline period as covariates. These characteristics are
considered to influence the utilization of inpatient ser-
vices related with hypertension. Patient characteristics
included demographic characteristics at the index date
(i.e., age and gender), overall health status measured by
the Elixhauser comorbidity index, and total medical
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of hypertension during the baseline period. The Elixhau-
ser index is a standard measure of comorbidity, which is
a count variable indicating the number of medical condi-
tions among 30 pre-defined comorbidities [16]. Index
scores range from a minimum of 0 to a maximum pos-
sible value of 30, with higher comorbidity indices indi-
cating sicker patients.
The characteristics of healthcare institutions at the
index date are presented in terms of type of institution,
ownership status, number of hospital beds, and location.
According to Korean medical law, healthcare institutions
are categorized into six types: clinic, public health center,
hospital, general hospital, tertiary-care hospital, and
long-term care facility. Ownership was classified into two
types: government-owned and non-government owned
hospitals. Location was categorized as the capital city of
Seoul, six major cities, and nine provinces. Lastly, the
healthcare institutions were categorized into five groups
according to the number of hospital beds: <100, 100–299,
300–799, 800–999, and ≥1,000.
Data analysis
We used descriptive statistics to compare the baseline
characteristics between the HI and the MA groups.
Two-tailed t-tests and chi-square tests were used to
compare differences in means and proportions, respect-
ively. We conducted all analyses using SAS statistical
software version 9.2 (SAS Institute Inc., Cary, NC, USA)
and STATA software version 10 (StataCorp LP, College
Station, TX, USA).
Hospital admission
We developed a multivariate logistic regression model to
assess whether there were significant differences in the
likelihood of hypertension-associated hospital admission
between HI and MA patients with hypertension after
controlling for baseline patient and institutional charac-
teristics. In addition to the Elixhauser comorbidity index
used as a continuous variable, measures of overall health-
care utilization, such as the total insurance-covered med-
ical costs and the total number of outpatient visits for all
causes during the 6-month baseline period, were included
in the model to adjust for patient baseline health status.
The c-statistic was examined to assess the model perform-
ance [17]. We examined the variance inflation factors to
check whether the model suffered from multicollinearity.
A value above 10 was considered to indicate a serious
multicollinearity problem [18].
Length-of-stay (LOS)
We used count data models such as Poisson and nega-
tive binomial regression models to compare the LOS be-
tween the HI and the MA group. Count data models aremore appropriate than standard linear regression models
for this outcome variable, which is a non-negative inte-
ger dependent variable [19]. The Poisson model implies
the equality of the conditional variance and the condi-
tional mean of the count variable, a property called
equidispersion [20]. When the variance exceeds the
mean, this overdispersion feature leads to inconsistent
and inefficient estimates. The negative binomial model
accounts for overdispersion by including the mean of
the count variable as a random variable following a
gamma distribution. Therefore, we employed the nega-
tive binomial model for the LOS variable because the
unconditional variances of this variable were larger than
the unconditional means. We also performed a likeli-
hood ratio test of the overdispersion parameter alpha,
where a significant p-value rejects the Poisson model in
favor of the negative binomial model. In addition, be-
cause the distribution of the LOS was markedly skewed
and the number of zeroes was excessive (93%), we
employed the zero-inflated negative binomial model
which accounts for both overdispersion and excess zer-
oes. We confirmed the use of the zero-inflated count
model by performing the Vuong test [19,20]. A signifi-
cant test result indicates that the zero-inflated count
model has a better fit than the standard count model.
Costs
We developed a cost model to assess whether there were
significant differences in the hospitalization costs be-
tween the HI and the MA group after controlling for
covariates. Healthcare expenditure data is typically char-
acterized by a nontrivial fraction of zero outcomes,
highly skewed to the right of non-zero outcomes, and
non-negative measurements of the outcomes [21]. If the
ordinary least squares (OLS) method is used to examine
the relationship between the type of insurance and
hospitalization costs, this approach may yield biased es-
timates since the OLS method is very sensitive to out-
liers. In addition, erroneous predictions such as negative
values may occur. Logarithmic transformation of expen-
ditures can be used to mitigate the skewness problem,
excluding observations with zero expenditure. However,
this approach may also yield biased estimates, and there-
fore Duan’s smearing estimator is used when heterosce-
dasticity exists [22].
Because the distribution of the hospitalization cost
variable was markedly skewed and heteroscedasticity
existed in our cost data as assessed by the generalized
linear model version of the Park test on the log-scale of
hospitalization costs, we did not use the OLS method
with logarithmic-transformed cost data, as otherwise the
estimation results would have been biased [21]. Instead,
we used an exponential conditional model (ECM) using
a generalized linear model framework, where the central
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mean, to estimate the factors influencing hospitalization
costs, and control for baseline demographic, comorbid-
ity, and hospital characteristics. The Box-Cox test and
the modified Park test were used to find the appropriate
link function and the distribution family for the
hospitalization cost variable. We used the Pregibon link
test to assess the model fit.
Results
We have included patients with at least one claim record
with hypertension. The minimum and maximum number
of claims in HI group (N = 304,027) were 1 (274 cases,
9%) and 321 (1 case, 0.0003%), respectively. The minimum
and maximum of claims in MA group (N = 21,539) were 1
(18 cases, 0.8357%) and 132 (1 case, 0.0046%), respectively.
The mean number of claims in HI group and MA group
were 16.1 (median 16.0) and 17.5 (median 17.0), respect-
ively. The numbers of patients who were hospitalized were
18,937 (6.23%) and 3,677 (17.07%) in HI group and MA
group, respectively.
Overall, enrollees in the two insurance programs ap-
peared to be heterogeneous in terms of demographic
characteristics and baseline health status (Table 1). Pa-
tients in the MA group were older and sicker compared
to those in the HI group (p <0.0001). The average Elix-
hauser comorbidity index of the MA patients (3.0) was
significantly higher than that of the HI patients (2.3),
with a higher score indicating poorer health. The average
insurance-covered medical costs for all causes and for
hypertension-associated conditions among MA patients
was about 2.37 and 2.19 times higher than among HI pa-
tients, respectively. More frequent ambulatory care visits
for hypertension-associated conditions (1.07 times, 4.6
visits for MA and 4.3 visits for HI patients) as well as for
all causes (1.13 times, 5.4 visits for MA and 4.8 visits for
HI patients) were observed among beneficiaries of the
MA program during the six-month baseline period.
The utilization of inpatient services related to hyperten-
sion during the one-year follow-up period was compared
between HI and MA patients (Table 2). The MA group
had a higher probability of hospitalization associated with
hypertension compared to the HI group. About 170.71
patients per 1,000 hypertension patients enrolled in the
MA program had at least one hypertension-associated
hospitalization, a rate three times higher than for those en-
rolled in the HI program (62.29 per 1,000 hypertension
patients). The average LOS per patient was also signifi-
cantly higher in the MA group (6.04 days) compared with
the HI group (1.27 days). On average, a patient enrolled
in the MA program had hospitalization costs (507,192
Korean won (KRW), 1 US dollar =1,200 KRW) nearly
three times higher than those in the HI program (175,892
KRW). Within the MA group, patients from the Class Igroup showed consistently higher utilization of inpatient
services compared to those from the Class II group in
terms of hospitalization rate, LOS, and costs.
The unit intensity of inpatient care measured as the aver-
age LOS and cost per admission was not consistently
higher in the MA group compared to the HI group. MA
patients stayed 15% longer (12.83 vs. 11.25 days), but spent
27% less during hospitalization (1,429,097 vs. 1,958,934
KRW).
For patients who had been hospitalized with hyper-
tension at least once during the follow-up period, we
conducted a subgroup analysis to examine the extent of
inpatient service utilization among those experiencing
hospitalization. For the MA group, the mean of the total
LOS per patient for one year was 35.39 days, which
leads to a calculation of 2.76 (=35.39/12.83) admissions
per patient. For the HI group, the mean of the total LOS
per patient was 20.39 days, indicating 1.83 (=20.39/
11.25) admissions per patient. For the hospitalization
cost variable, the difference between the two groups
was very marginal, with a difference of only 1.05 times
(2,823,890 KRW for the HI group and 2,971,010 KRW
for the MA group).
We conducted a multivariate logistic regression ana-
lysis to examine whether the difference in the probability
of hospital admission for hypertension between the two
insurance groups remained after controlling for baseline
characteristics (Table 3). Patients in the MA group had a
greater likelihood of being hospitalized compared with
patients in the HI group, as reflected in the significant
odds ratio (OR) of 1.71 (95% CI =1.63-1.79) and 1.41
(95% CI =1.27-1.57) for the MA Class I and Class II
groups, respectively. Older age, higher medical costs (all
causes), fewer outpatient visits (all causes), and higher
comorbidity were all significantly associated with a
greater likelihood of hospital admission (p <0.0001). The
c-statistic was 0.78, indicating that the model performed
very well. The model did not suffer from a multicolli-
nearity problem because all variance inflation factors
were below 10 and tolerance values were above 0.1.
To compare the extent of hypertension-associated
inpatient services used between the two groups after
adjusting for baseline characteristics, we employed a zero-
inflated negative binomial count model for the total LOS
per patient (Table 3). The estimated value of the overdis-
persion parameter alpha was positive (value =1.48; 95%
CI =1.44-1.53) and the likelihood ratio test was significant,
indicating that the negative binomial model was preferred
to the Poisson model (p <0.0001). We had significant re-
sults for the Vuong test, which supported the zero-inflated
negative binomial model over the negative binomial model
for the LOS outcome (p <0.0001).
Among patients who were hospitalized when sick, the
expected total LOS per patient in the MA Class I and
Table 1 Baseline characteristics of enrollees in the National Health Insurance and Medical Aid programs
National Health Insurance (N = 304,027) Medical Aid (N = 21,539) p-value
Patient characteristics during the 6-month baseline period
Medical Aid
Class Ia, n (%) - 17,248 (80.1) -
Class IIb, n (%) - 4,291 (19.9) -
Age in years, mean (SD) 61.6 (11.7) 68.1 (11.9) <0.0001
Male, n (%) 130,398 (42.9) 6,000 (27.9) <0.0001
Insurance-covered medical costs in Korean wonc, mean (SD)
All causes 228,566 (838,665) 541,699 (1,359,656) <0.0001
Hypertension relatedd 171,249 (616,724) 375,440 (995,523) <0.0001
No. outpatient visits, mean (SD)
All causes 4.8 (2.6) 5.4 (2.7) <0.0001
Hypertension related 4.3 (2.3) 4.6 (2.0) <0.0001
Elixhauser comorbidity indexe, mean (SD) 2.3 (1.3) 3.0 (1.7) <0.0001
n (%)
1 103,722 (34.1) 4,074 (18.9) <0.0001
2 92,830 (30.5) 5,614 (26.1)
3 57,212 (18.8) 4,684 (21.8)
4 28,815 (9.5) 3,160 (14.7)
≥5 21,448 (7.1) 4,007 (18.6)
Characteristics of healthcare institution at index visit
Type of institution, n (%) <0.0001
Tertiary-care hospital 19,101 (6.3) 536 (2.5)
General hospital 28,703 (9.4) 3,586 (16.7)
Hospital 14,174 (4.7) 2,185 (16.7)
Long-term care facility 1,026 (0.3) 368 (1.7)
Clinic 203,556 (67.0) 11,432 (53.1)
Public health center 36,740 (12.1) 2,288 (10.6)
Type of ownership, n (%) <0.0001
Government owned 40,031 (13.2) 3,086 (14.3)
Non-government owned 263,947 (86.8) 18,449 (85.7)
Missing 49 (0.0) 4 (0.0)
Bed size, n (%) <0.0001
<100 248,378 (81.7) 15,818 (73.4)
100 ~ 299 17,077 (5.6) 2,790 (13.0)
300 ~ 799 24,925 (8.2) 2,281 (10.6)
800 ~ 999 7,377 (2.4) 435 (2.0)
≥1,000 6,270 (2.1) 215 (1.0)
Location, n (%) <0.0001
Seoul 72,002 (23.7) 3,190 (14.8)
Six major cities 73,653 (24.2) 5,329 (24.7)
Kwangju 7,457 (2.5) 761 (3.5)
Daegu 14,106 (4.6) 1,056 (4.9)
Daejeon 8,787 (2.9) 641 (3.0)
Pusan 22,703 (7.5) 1,706 (7.9)
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Table 1 Baseline characteristics of enrollees in the National Health Insurance and Medical Aid programs (Continued)
Ulsan 5,261 (1.7) 264 (1.2)
Incheon 15,339 (5.1) 901 (4.2)
Nine provinces 158,323 (52.1) 13,016 (60.4)
Kangwon 11,442 (3.8) 1,084 (5.0)
Kyonggi 59,167 (19.5) 3,065 (14.2)
Kyungsangnam 17,754 (5.8) 1,432 (6.7)
Kyungsangbuk 16,935 (5.6) 1,680 (7.8)
Jeollanam 13,100 (4.3) 1,921 (8.9)
Jeollabuk 12,466 (4.1) 1,706 (7.9)
Jeju 3,279 (1.1) 236 (1.1)
Chungcheongnam 14,200 (4.7) 1,058 (4.9)
Chungcheongbuk 9,980 (3.3) 834 (3.9)
Missing 49 (0.0) 4 (0.0)
aBeneficiaries of Medical Aid who are not able to work at all; bBeneficiaries of Medical Aid who are able to work; cAll costs are presented in 2006 Korean currency
value (1,200 Korean won [KRW] =1 US dollar); dHypertension-related visits are defined as visits with a primary, secondary, tertiary, or quaternary diagnosis of
hypertension; eThe higher the comorbidity indices, the sicker patients are; SD = standard deviation.
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1.42 times (95% CI =1.26-1.59) longer than in the HI
group, respectively. Patients in the MA Class I and Class
II groups had a significantly higher probability of being
in the certain admission group compared with those in
the HI group.
For the cost model examining the relationship be-
tween type of insurance and hospitalization costs, the
Box-Cox test and the modified Park test indicated that
the appropriate generalized linear model was a gamma
distribution with a log link function. The Pregibon LinkTable 2 Comparison of utilization of hypertension-related inp




No. patients hospitalized with HTN per 1,000 patients 62.29
Average LOS per patient in days (SD) 1.27
(11.22)
Average cost for ICS per patient (SD) 175,89
(1,136,
Average LOS per admission in days (SD) 11.15
(11.19)
Average cost for ICS per admission (SD) 1,958,9
(2,298,
Average LOS per patient hospitalized with HTN in days (SD) 20.39
(40.38)
Average cost for ICS per patient hospitalized with HTN (SD) 2,823,8
(3,640,
SD = standard deviation; LOS = length of stay; HTN = hypertension; ICS = insurance-cov
secondary, tertiary, or quaternary diagnosis of hypertension; All costs are presented intest showed that the model performed well (p =0.559).
After controlling for covariates, the predicted incurred
costs of hospitalization for the MA Class I group were
approximately 41% higher than the costs for the HI
group. However, the predicted costs for the MA Class
II group were not significantly higher than those for the
HI group.
Discussion
In this study, we examined whether the type of health





All Class I Class II




2 507,192 562,100 286,482
418) (1,921,397) (2,008,176) (1,503,610)
12.83 12.98 11.79
(10.94) (10.99) (10.49)
34 1,429,097 1,433,674 1,396,845
445) (1,749,599) (1,730,079) (1,883,112)
35.39 36.09 30.42
(61.14) (61.40) (59.07)
90 2,971,010 3,010,903 2,689,922
973) (3,782,638) (3,772,490) (3,845,845)
ered services; All inpatient services were hypertension-related, with a primary,
2006 Korean currency value (1,200 Korean won [KRW] =1 US dollar).
Table 3 Regression analysis results for the association between type of health insurance and utilization of
hypertension-related inpatient services among patients with hypertension
Hospital admission Length of stay Hospitalization costs
Odds ratio [95% CI] Factor changea [95% CI] Factor changea [95% CI]
Type of insurance
Medical Aid Class Ib 1.710*** 1.305*** 1.412***
[1.632-1.792] [1.243-1.370] [1.289-1.545]
Medical Aid Class IIc 1.413*** 1.419*** 1.103
[1.271-1.570] [1.263-1.594] [0.907-1.340]
Health Insurance [ref] - - -
Age 1.029*** 1.014*** 1.037***
[1.028-1.030] [1.013-1.016] [1.035-1.040]
Gender
Male 0.999 0.992 0.893**
[0.969-1.030] [0.959-1.027] [0.839-0.951]
Female [ref] - - -
Total costs for insurance-covered services (all causes)d 1.013*** 1.012*** 1.024***
[1.012-1.014] [1.011-1.013] [1.022-1.027]
Total No. outpatient visits (all causes) 0.981*** 0.970*** 0.988*
[0.975-0.986] [0.966-0.974] [0.978-0.998]
Elixhauser comorbidity index 1.577*** 1.074*** 1.784***
[1.563-1.592] [1.064-1.084] [1.749-1.822]
Ownership of institution
Non-government owned 1.004 0.891 1.197*
[0.910-1.107] [0.805-0.986] [1.013-1.416]
Government owned [ref] - - -
Type of institution
Tertiary hospital 2.117*** 0.544*** 1.240**
[2.005-2.235] [0.505-0.585] [1.091-1.409]
General hospital 1.923*** 0.713*** 1.065
[1.844-2.006] [0.670-0.758] [0.949-1.194]
Hospitale [ref] 2.240*** - -
[2.126-2.360]
Long-term care facility 5.213*** 2.919*** 2. 474***
[4.580-5.933] [2.583-3.300] [2.024-3.022]
Public health center 1.260*** 0.696*** 0.880
[1.130-1.406] [0.616-0.786] [0.715-1.084]
Clinicf [ref] - 0.673*** 0.549***
[0.636-0.712] [0.496-0.607]
Location of institution
Six major cities 1.134*** 1.358*** 0.992
[1.085-1.185] [1.293-1.426] [0.907-1.085]
Nine provinces 1.248*** 1.145*** 1.046
[1.200-1.298] [1.096-1.196] [0.968-1.131]
Seoul [ref] - - -
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Table 3 Regression analysis results for the association between type of health insurance and utilization of
hypertension-related inpatient services among patients with hypertension (Continued)
c-statistic 0.778
Dispersion parameter 1.481
P-value for LR testg < 0.0001
Vuongstatistich 93.73***
All inpatient services were hypertension-related, with a primary, secondary, tertiary, or quaternary diagnosis of hypertension; Robust standard errors in parenthesis;
All covariates at index-date otherwise specified; aExp (coefficient estimate) = factor change in expected hospitalization costs for a unit increase in a covariate;
bBeneficiaries of Medical Aid who are not able to work at all; cBeneficiaries of Medical Aid who are able to work; dInsurance-covered medical costs during the
6-month baseline period in 2006 Korean won (one US dollar approximately equals 1,200 Korean won); eHospital used as a reference for length-of-stay and
hospitalization costs variable; fClinic used as a reference for the hospital admission variable; gLikelihood Ratio (LR) test comparing negative binomial model against
Poisson model; hComparing zero-inflated negative binomial model against negative binomial model; * p <0.05; ** p <0.001; *** p <0.0001; SE = standard error;
95% CI =95% confidence interval.
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fects the extent of healthcare utilization under the uni-
versal health insurance system in Korea. While the
beneficiaries of the contributory program (National
Health Insurance) pay wage-based insurance premiums
and out-of-pocket co-payments for healthcare services,
the beneficiaries of the public assistance program (Med-
ical Aid) do not pay insurance premiums and most of
their co-payments are waived. The low prices or ex-
penses paid by MA enrollees may lead to low concern
for the efficient use of healthcare resources, resulting in
higher utilization of healthcare services.
Our study results provide empirical evidence that
hypertension patients in the MA program tend to utilize
more healthcare resources for their inpatient care than
those in the HI program. Patients in the MA program
tended to get hospitalized more often, and incurred
higher hospitalization costs and longer inpatient stays to
treat hypertension-associated conditions than their
counterparts from the HI program. This tendency per-
sisted even after controlling for the patients’ baseline
health status and characteristics of healthcare institu-
tions in a series of multivariate regression models. This
phenomenon is expected considering the findings from
previous literatures [3,23,24].
Interestingly, while the likelihood of being hospitalized
and the per capita utilization of inpatient services in
terms of inpatient days and costs were significantly
higher among MA program hypertension patients, the
unit intensity of inpatient care (i.e., average LOS and
cost per admission) was very similar or even lower in
MA patients. This implies that the discrepancy in the
utilization of inpatient services between the two groups
may be mainly attributable to more frequent hospital ad-
missions among the MA group, but may not be attribut-
able to higher intensity or use of healthcare resources
during hospitalization. The similar LOS and cost per ad-
mission suggests that the disease severity treated during
hospitalization may not be higher in the MA group
compared to the HI group. Another possibility is thatthe same standard of care is provided for hypertension-
associated conditions in the inpatient setting in Korea
regardless of the health plan in which patients are en-
rolled, resulting in similar LOS and cost per admission
among all patients.
A comparison of the descriptive statistics of the pa-
tient characteristics considered in the present study indi-
cates that the overall health status of the MA patients
was worse than that of the HI patients. The MA patients
were older, had higher comorbidity scores, incurred
more medical costs, and had more ambulatory care visits
than the HI patients. The discrepancy between the two
groups with regard to baseline health status suggests
that rigorous multivariate regression methods are essen-
tial to examine the unbiased independent relationship
between the insurance type and the outcome variables.
Therefore, in the present study we determined the most
appropriate type of multivariate regression model for
each outcome variable. For example, we chose the zero-
inflated negative binomial model for the outcome vari-
able of LOS in order to account for both overdispersion
and excess zeroes. In addition, a generalized linear
model with a log-link function was employed for the
cost variable because of the nature of the cost data hav-
ing high skewness and heteroscedasticity. A series of test
statistics (i.e., the Vuong test, likelihood ratio test, and
others) confirmed that these models were the best
choices for each outcome variable.
We also attempted to adjust for patients’ baseline charac-
teristics, health conditions, and institutional characteristics
in the regression models using patient-level information
available in the insurance claims records as much as
possible. As a consequence, we observed a substantial re-
duction in differences in inpatient service utilization be-
tween the HI and the MA patients in the multivariate
regression models. For instance, a three-fold difference in
the hypertension-associated hospitalization rate between
the two groups (62.29 per 1,000 patients for the HI group
and 170.71 for the MA group, Table 2) was reduced to a
1.41- to 1.71-folddifference (presented as odds ratio, Table 3)
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two groups. For the hypertension-associated LOS, a differ-
ence of 4.76 times (1.27 days per patient for the HI group
and 6.04 days for the MA group, Table 2) was reduced to
1.31 to 1.42 times (Table 3). Lastly, the hospitalization cost
for hypertension-associated conditions was decreased to
1.093 to 1.412 times (Table 3) from 2.88 times (175,892
KRW per patient for the HI group and 507,192 KRW for
the MA group, Table 2).
These observations suggest that differences in the
baseline condition may play a substantial role in explain-
ing why MA patients with hypertension tended to use
more inpatient services than their counterparts in the
HI program. However, although the extent of higher
utilization of inpatient care by the MA group was de-
creased after adjusting for the differences in baseline
health conditions, the positive associations between MA
insurance status and higher utilization of inpatient ser-
vices remained statistically significant for all three out-
come variables. Therefore, based on the results of our
empirical analysis, we can conclude that the initial hy-
pothesis was supported: higher admission rates by MA
patients persisted after adjustment for differences in
baseline health condition and characteristics between
the two groups, suggesting the overutilization of in-
patient care in the treatment of hypertension for patients
in the MA program.
It is possible that MA patients have higher rates of
hospitalization because their primary care for hyperten-
sion is not sufficient or appropriate compared to HI pa-
tients. However, the utilization of ambulatory care
services for cases with a primary diagnosis of hyperten-
sion was similar between the two groups: 4.3 outpatient
visits for HI patients and 4.6 visits for MA patients dur-
ing the baseline six-month period in this study. This
does not support the hypothesis that insufficient primary
care characterizes the treatment of hypertension in MA
patients. There is no restriction in the type of healthcare
institution that MA patients are allowed to use, meaning
that both HI and MA patients have access to all medical
institutions without restrictions. In addition, because the
same list of insurance-covered services is available to
treat both HI and MA patients under the NHI system in
Korea, the possibility of discriminating behavior from
physicians in choosing appropriate anti-hypertensive
drugs depending on the insurance type (MA or HI) is
considered very low. Unlike other conditions that re-
quire the use of expensive uninsured medicines and pro-
cedures, most antihypertensive medicines are covered by
the NHI. Thus, inaccessibility to expensive non-covered
medication cannot be a contributing factor in the differ-
ent quality of care between MA and HI patients. How-
ever, although the same extent and quality of care may
be provided, the patients’ poor self-management interms of medication compliance, diet, and exercise may
affect the quality of care and hospitalization. Conse-
quently, we cannot confirm whether the higher utilization
of hypertension-related inpatient services by MA patients
is attributed to their unnecessary overutilization of the ser-
vices or to the unsuccessful prevention of hospital admis-
sion due to the low quality of outpatient care for MA
patients. Thus, we suggest a future study to identify the
causes of higher utilization of inpatient services by hyper-
tension patients in the MA program.
As the national health insurance system was employed in
1989 achieving universal healthcare coverage in Korea, we
are facing fiscal challenges and various methods are being
discussed [25,26]. Raising copayment rates or deductibles
have been used as a means of reducing overutilization [23].
The evidence suggests that such plans would reduce
healthcare utilizations [3,24]. However, this could be asso-
ciated with worse outcomes if patients defer necessary
care. Some evidence suggests that lowering copayments
or deductibles would have positive health consequences
or vice versa [27,28]. Thus, a careful approach should
be employed to prevent overutilization of inpatient ser-
vices after identifying the causes of overutilization in
the MA program.
Several limitations of the present study should be ad-
dressed in future studies. First, the beneficiaries who
switched between the HI and the MA program during
the study period were not included in this study. This
may affect the generalizability of the study findings.
However, because the proportion of the MA enrollees in
Korea has remained stable at around 3.5% for a decade,
we believe that this limitation had little effect on the
study findings [5]. Second, our study was restricted to
patients who had claim records during both the six-
month baseline period and the one-year follow-up
period in order to provide complete information for the
study subjects. This sampling process may have resulted
in the inclusion of either sicker patients or more health-
conscious patients. Third, the reliance on diagnostic
codes to identify hypertension patients may have caused
misclassification of the target patients due to the nature
of claims data, such as voluntary or involuntary miscod-
ing behavior. However, a recent validation study for the
diagnostic codes of the NHI claims database in Korea
addressed this concern. The validation study found that
about 70% of the primary, secondary, or tertiary diagno-
sis codes from the NHI claims records coincided with
those from medical records [29,30]. Fourth, due to the
limited clinical information available in the claims data-
base, we were not able to adjust the baseline severity
of hypertension for each patient using laboratory infor-
mation such as blood pressure. Instead, the Elixhauser
comorbidity index and overall healthcare utilization ob-
served during the baseline period were used as proxy
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individual patients into the analysis. Lastly, the ECM
cost model may yield inconsistent estimates if the link
function and underlying family distribution are not cor-
rectly specified and the cost estimation might be numer-
ically unstable if there are many zeros [31]. However, we
chose the link function and distribution based on statis-
tical tests and these results might attenuate the concern
over inconsistent estimates. In order to determine the
appropriate relationship between the types of insurance
and hospitalization costs, the patients with zero costs
need to be included in the model. Because we found het-
eroscedasticity, using a model that requires transforming
and retransforming the cost variable would have led to
biased estimates. Thus, the cost model we used, which
accommodated for skewness, was considered to be the
most appropriate for examining the relationship between
the insurance type and hospitalization costs.
Conclusions
In conclusion, hypertension patients in the MA group
showed a substantially higher utilization and cost of in-
patient services for treating hypertension or associated
conditions than those in the HI group. The finding of
higher total hospitalization costs and LOS per patient,
but similar unit cost and LOS per admission among MA
patients, suggests that more frequent admissions are a
major factor in the higher utilization of inpatient care in
this group. Thus, focusing on methods to prevent epi-
sodes of hospital admission seems to be the most appro-
priate strategy for reducing the potential overutilization
of inpatient care or low quality of primary care among
hypertension patients in the MA program.
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